Prevention of breast cancer using rexinoids: results of a phase II biomarker modulation trial using bexarotene in women at high risk of breast cancer.

被引：0
|
作者：
Brown, P. [1 ,2 ,3 ,4 ,5 ,6 ]
Arun, B. [1 ,2 ,3 ,4 ,5 ,6 ]
Miller, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Isaacs, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Gutierrez, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Huang, J. [1 ,2 ,3 ,4 ,5 ,6 ]
Mohsin, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Sneige, N. [1 ,2 ,3 ,4 ,5 ,6 ]
Kim, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Sexton, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Weiss, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Hilsenbeck, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Lamph, W. [1 ,2 ,3 ,4 ,5 ,6 ]
Negro-Vilar, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Johnson, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Elledge, R. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA
[4] Georgetown Univ, Washington, DC USA
[5] Ligand Pharmaceut, San Diego, CA USA
[6] Natl Canc Inst, Bethesda, MD USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S181 / S182
页数：2
相关论文
共 50 条
  • [31] Biomarker modulation by bazedoxifene and conjugated estrogen (Duavee®) in women at high risk for development of breast cancer
    Fabian, Carol J.
    Nye, Lauren
    Phillips, Teresa A.
    Winblad, Onalisa
    Zalles, Carola M.
    Hagan, Christy R.
    Goodman, Merit L.
    Gajewski, Byron J.
    Koestler, Devin C.
    Chalise, Prabhakar
    Kimler, Bruce F.
    CANCER RESEARCH, 2020, 80 (04)
  • [32] The reliability of ductal lavage in women at high risk for breast cancer.
    Visvanathan, K
    Santor, D
    Ali, S
    Brewster, A
    Arnold, A
    Armstrong, D
    Helzlsouer, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 106S - 106S
  • [33] A pilot phase II trial of cabergoline in the treatment of metastatic breast cancer.
    Costa, Ricardo Lima Barros
    Santa-Maria, Cesar Augusto
    Scholtens, Denise M.
    Jain, Sarika
    Gradishar, William John
    Clevenger, Charles V.
    Kaklamani, Virginia G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Interim analysis of a phase I dose escalation study of topical bexarotene in women at high risk for breast cancer
    Thomas, Parijatham S.
    Patel, Anisha B.
    Liu, Diane
    Lee, J. Jack
    Khan, Seema
    Muzzio, Miguel
    Contreras, Alejandro
    Vornik, Lana
    Dimond, Eileen P.
    Perloff, Marjorie
    Heckman-Stoddard, Brandy
    Brown, Powel H.
    CANCER RESEARCH, 2021, 81 (04)
  • [35] Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?
    Francesco Sardanelli
    Franca Podo
    European Radiology, 2007, 17
  • [36] Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?
    Sardanelli, Francesco
    Podo, Franca
    EUROPEAN RADIOLOGY, 2007, 17 (04) : 873 - 887
  • [37] Effect of anastrozole on cholesterol fractions in postmenopausal women with high risk of breast cancer: results from IBIS-II breast cancer prevention study.
    Singh, S.
    Richmond, B.
    Howell, A.
    Cuzick, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S57 - S57
  • [38] Tamoxifen and the prevention of breast cancer in high-risk women
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (04):
  • [39] Tamoxifen and the Prevention of breast cancer in high-risk women
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 68 (01) : 73 - 75
  • [40] Melanoma risk in women with previous breast cancer.
    Weitzen, R
    Harari, G
    Achiron, A
    Catane, R
    Mandel, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 723S - 723S
12345